Statistical classification of abnormal blood profiles in athletes

International Journal of Biostatistics

Volumn 2, Issue 1, 2006, Pages

  Sottas, Pierre Edouard ^a   Robinson, Neil ^a   Giraud, Sylvain ^a   Taroni, Franco ^a   Kamber, Matthias ^b   Mangin, Patrice ^a   Saugy, Martial ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Swiss Federal Office for Sports   (Switzerland)

Author keywords

Biomarkers; Blood doping; Cross validation; Forensic standards; Scientific evidence; Statistical classification

Indexed keywords

BIOLOGICAL MARKER; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADULT; ALGORITHM; ARTICLE; ATHLETE; BLOOD AUTOTRANSFUSION; BLOOD EXAMINATION; BLOOD SAMPLING; BLOOD TRANSFUSION; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPING; DOUBLE BLIND PROCEDURE; DRUG ABUSE; ERYTHROPOIESIS; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HEMATOLOGY; HUMAN; MALE; MEDICOLEGAL ASPECT; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; REFERENCE DATABASE; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL; VALIDATION PROCESS;

EID: 33645862262     PISSN: 15574679     EISSN: None     Source Type: Journal    
DOI: 10.2202/1557-4679.1011     Document Type: Article

References (37)

1. Aitken, C., & Taroni, F. 2004. Statistics and the evaluation of evidence for forensic scientists. 2nd edn. Chichester: John Wiley & Sons.
2. Ashenden, M. J. 2002. A strategy to deter blood doping in sport. Haematologica, 87, 225-234.
3. Ashenden, M. J., Sharpe, K., Damsgaard, R., & Jarvis, L. 2004. Standardisation of reticulocyte values in an antidoping context. Am J Clin Pathol, 121(6), 816-825.
4. Audran, M., Gareau, R., Matecky, S., Durand, F., Chenard, C., Sicard, M.T., Marion, B., & Bressolle, F. 1999. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exercise, 31(5), 639-645.
5. Azzalini, A., & Capitanio, A. 1999. Statistical applications of the multivariateskew-norrnal distribution. Journal of the Royal Statistical Society B, 61, 987-989.
6. Berger, J.O., & Berry, D.A. 1988. Statistical analysis and the illusion of objectivity. Amer Scient, 76, 159-165.
7. Berglund, B., P., Hemmingsson, & G., Birgegard. 1987. Detection of autologous blood transfusions in cross-country skiers. Int. J. Sports Med., 8(2), 66-70.
8. Canu, S., Grandvalet, Y, & Rakotomamonjy, Y. 2003. SVM and Kernel Methods Matlab Toolbox.
9. Casoni, I., Ricci, G., Ballarini, E., Borsetto, C., Grazzi, G., Guglielmini, C., Manfredini, F., Mazzoni, G., Patracchini, M., & Paoli, E. V. De. 1993. Hematological indices of erythropoietin administration in athletes. Int. J. Sports Med., 14, 307-311.
10. Cazzola, M. 2000. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica, 85, 561-563.
11. Coombs, R.R.A. 1970. History and evolution of the anti-globin reaction and its application in clinical and experimental medicine. Am. J. Clin. Path, 53, 131-135.
12. Duda, R.O., Hart, P.E., & Stork, D.G. 2001. Pattern classification. 2nd edn. New York: Wiley-Interscience.
13. Edwards, A.W.F. 1970. Likelihood. Nature, 227,92.
14. Ekblom, B., & Berglund, B. 1991. Effects of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports, 1, 88-93.
15. Ekblom, B., Goldberg, A., & Gullbring, B. 1972. Response to exercise after blood loss and reinfusion. J. Appl. Physiol., 33, 175-180.
16. Evett, I.W. 1996. Expert evidence and forensic misconceptions of the nature of exact science. Sci. and Just., 36, 118-122.
17. Fienberg, S.E. 1989. The Evolving Role of Statistical Assessments as Evidence in the Courts. Heidelberg: Springer.
18. Friedman, N., Geiger, D., & Goldszmidt, M. 1997. Bayesian network classifiers. Machine Learning, 29, 131-163.
19. Gaudard, A., Varlet-Marie, E., Bressolle, F., & Audran, M. 2003. Drugs for increasing oxygen and their potential use in doping: a review. Sports Med, 33, 187-212.
20. Gore, C.J., Parisotto, R., Ashenden, M.J., Stray-Gundersen, J., Sharpe, K., Hopkins, W., Emslie, K.R., Howe, C., Trout, G.J., Kazlauskas, R., & Hahn, A.G. 2003. Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica, 88, 333-344.
21. Guyon, I., & Elisseeff, A. 2003. An introduction to variable and feature selection. J Mach Learn Res, 3, 1157-1182.
22. Hand, D.J., & Yu, K. 2001. Idiot's Bayes - not so stupid after all? Int Stat Review, 69, 385-399.
23. Hansen, L.K., Larsen, J., & Kolenda, T. 2001. Blind Detection of Independent Dynamic Components. vol. 5.
24. Hjorth, J.S.U. 1994. Computer Intensive Statistical Methods Validation, Model Selection, and Bootstrap. London: Chapman & Hall.
25. Lasne, F., & de Ceaurriz, J. 2000. Recombinant erythropoietin in urine. Nature, 405, 635.
26. Nelson, M., Ashenden, M., Langshaw, M., & Popp, H. 2002. Detection of homologous blood transfusion by flow cytometry: a deterrent against blood doping. Haematologica, 87, 881-882.
27. Parisotto, R., Wu, M., Ashenden, M.J., Emslie, K.R., Gore, C.J., Howe, C., Kazlauskas, R., Sharpe, K., Trout, G.J., Xie, M., & Hahn, A.G. 2001. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica, 86, 128-137.
28. Robinson, N. 2003. Blood manipulation in endurance sports. Ph.D. thesis, University of Lausanne.
29. Robinson, N., Saugy, M., Buclin, T., Gremion, G., & Mangin, P. 2001. The interpretation of secondary blood markers can get hazardous in case of a discontinuous rhEPO treatment. Haematologica, 6, 87.
30. Schoelkopf, B., & Smola, A.J. 2001. Learning with Kernels: Support Vector Machines, Regularization, Optimization, and Beyond. Boston: MIT press.
31. Sharpe, K., Hopkins, W., Emslie, K.R., Howe, C., Trout, G.J., Kazlauskas, R., Ashenden, M.J., Gore, C.J., Parisotto, R., & Hahn, A.G. 2002. Development of reference ranges in elite athletes for markers of altered erythropoiesis. Haematologica, 87, 1248-1257.
32. S.Haykin. 1998. Neural Networks: A Comprehensive Foundation. 2nd edn. Upper Saddle River: Prentice Hall.
33. Silverman, B.W. 1986. Density Estimation for Statistics and Data Analysis. London: Chapman and Hall.
34. Stray-Gundersen, J., Videman, T., Penttila, I., & Lereim, I. 2003. Abnormal Hematologic Profiles in Elite Cross-Country Skiers: Blood Doping or? Clin J Sport Med, 13, 132-137.
35. Vergouwen, P.C., Collee, T., & Marx, J.J. 1999. Hematocrit in elite athletes. Int. J. Sports Med., 20, 538-541.
36. Videman, T., Lereim, I., Hemmingsson, P., Turner, M.S., Rousseau-Bianchi, M.P., Jenoure, P., Raas, E., Schonhuber, H., Rusko, H., & Stray-Gundersen, J. 2000. Changes in hemoglobin values in elite cross-country skiers from 1987 to 1999. J. Scand J Med Sci Sports, 10, 98-102.
37. Wide, L., Bengtsson, C., Berglund, B., & Ekblom, B. 1995. Detection in blood and urine of recombinant erythropoietin administrated to healthy men. Med. & Sci. in Sports & Exerc., 27, 1569-1576.